益气活血法对舒张性心力衰竭气虚血瘀证患者的影响

摘要
图/表
参考文献(27)
相关文章 (15)

全文: PDF (744 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要目的观察益气活血法对舒张性心力衰竭（DHF）气虚血瘀证患者的影响。方法选取2017年1月—2019年11月廊坊市中医医院心内科收治的89例气虚血瘀证DHF患者，按就诊奇偶数将其分为对照组（44例）和观察组（45例）。对照组给予西医基础对症治疗，观察组在此基础上加用益肾强心汤治疗，均治疗8周。比较两组治疗前后中医证候积分、疗效、心功能指标、心室重构指标及细胞因子水平。结果治疗8周，两组心悸气短、气喘、胸闷隐痛、神疲乏力、胸胁胀痛积分均低于治疗前，且观察组低于对照组，差异有统计学意义（P < 0.05）。治疗后，观察组疗效优于对照组，差异有统计学意义（P < 0.05）。治疗8周，两组心功能分级、二尖瓣舒张早期血流峰值速度（E）/舒张中晚期血流峰值速度（A）高于治疗前，E快于治疗前，6 min步行试验（6MWT）长于治疗前，且观察组心功能分级、E/A高于对照组，E快于对照组，6MWT长于对照组，差异有统计学意义（P < 0.05）。治疗8周，两组左室舒张末期内径（LVEDD）、舒张末期室间隔厚度（IVST）短于治疗前，左室舒张末期容积（LVEDV）小于治疗前，左心室质量指数（LVMI）低于治疗前，且观察组LVEDD、IVST短于对照组，LVEDV小于对照组，LVMI低于对照组，差异有统计学意义（P < 0.05）。治疗8周，两组肌钙蛋白I（cTnI）、高敏C反应蛋白（hs-CRP）、血管紧张素Ⅱ（AngⅡ）、血管性假血友病因子（vWF）水平均低于治疗前，且观察组低于对照组，差异有统计学意义（P < 0.05）。结论益肾强心汤联合西医基础对症治疗气虚血瘀证DHF的效果优于单独西医治疗，可改善患者心功能，减轻心室重构，降低cTnI、hs-CRP、AngⅡ、vWF等炎症及促血管收缩因子水平。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	刘晓霞1 王君1 沈晓旭2

关键词 ：舒张性心力衰竭, 气虚血瘀证, 中医, 益气活血, 肌钙蛋白I, 心功能

Abstract：Objective To observe the effect of benefiting qi for activating blood circulation method on diastolic heart failure (DHF) patients with syndrome of qi deficiency and blood stasis. Methods Eighty-nine DHF patients with syndrome of qi deficiency and blood stasis in Department of Cardiology of Langfang Hospital of Traditional Chinese Medicine from January 2017 to November 2019 were selected and divided into control group (44 cases) and observation group (45 cases) according to odd and even number. Control group was given basic symptomatic treatment of Western medicine, and observation group was additionally treated with Yishen Qiangxin Decoction for eight weeks. Traditional Chinese medicine syndrome score, curative effect, cardiac function index, ventricular remodeling index and cytokine levels before and after treatment were compared between two groups. Results After eight weeks of treatment, the scores of palpitation and shortness of breath, asthma, chest tightness and dull pain, mental fatigue and chest pain in two groups were lower than those before treatment, and observation group was lower than that of control group, the differences were statistically significant (P < 0.05). The curative effect of observation group was better than that of control group, and the difference was statistically significant (P < 0.05). After eight weeks of treatment, cardiac function grade, peak velocity of early diastolic mitral flow (E)/peak velocity of mid late diastolic blood flow (A) of two groups were higher than those before treatment, E of two groups was faster than that before treatment, six-minute walk test (6MWT) of two groups was longer than that before treatment, and cardiac function grade, E/A of observation group were higher than those of control group, E of observation group was faster than that of control group, 6MWT of observation group was longer than that of control group, the differences were statistically significant (P < 0.05). After eight weeks of treatment, the left ventricular end diastolic diameter (LVEDD), end diastolic ventricular septal thickness (IVST) of two groups were shorter than those before treatment, left ventricular end diastolic volume (LVEDV) of two groups was less than that before treatment, left ventricular mass index (LVMI) of two groups was lower than that before treatment, and LVEDD and IVST of observation group were shorter than those of control group, LVEDV of observation group was less than that of control group, LVMI of observation group was lower than that of control group, the differences were statistically significant (P < 0.05). After eight weeks of treatment, the levels of cardiac troponin I (cTnI), high sensitivity C-reactive protein (hs-CRP), angiotensin Ⅱ (Ang Ⅱ) and von Willebrand factor (vWF) in two groups were lower than those before treatment, and observation group was lower than that of control group, the differences were statistically significant (P < 0.05). Conclusion Yishen Qiangxin Decoction combined with Western medicine in treating DHF with syndrome of qi deficiency and blood stasis is more effective than Western medicine alone. It can improve cardiac function of patient, alleviate ventricular remodeling and reduce levels of inflammatory and vasoconstrictive factors, such as cTnI, hs-CRP, AngⅡ and vWF.

Key words： Diastolic heart failure Syndrome of qi deficiency and blood stasis Chinese medicine Benefiting qi for activating blood cirulation Cardiac troponin I Cardiac function

基金资助:国家自然科学基金资助项目（81473517）。

引用本文:

刘晓霞1 王君1 沈晓旭2. 益气活血法对舒张性心力衰竭气虚血瘀证患者的影响[J]. 中国医药导报, 2021, 18(7): 117-121,135.
LIU Xiaoxia1 WANG Jun1 SHEN Xiaoxu2. Effect of benefiting qi for activating blood circulation method on diastolic heart failure patients with syndrome of qi deficiency and blood stasis. 中国医药导报, 2021, 18(7): 117-121,135.

链接本文:

http://www.yiyaodaobao.com.cn/CN/ 或 http://www.yiyaodaobao.com.cn/CN/Y2021/V18/I7/117

[1] Gaasch WH. Deliberations on diastolic heart failure [J]. Am J Cardiol，2017，119（1）：138-144.
[2] Schwartz RG，Venci N. Can serial changes of diastolic dysfunction signal incremental risk of chemotherapy-induced heart failure missed by the timing of declining LV ejection fraction? [J]. J Nucl Cardiol，2016，23（4）：833-836.
[3] 李冀，李想，曹明明，等.中医益气活血法治疗心系疾病[J].辽宁中医药大学学报，2020，22（2）：1-4.
[4] 李伟英，苗梦露.中西医结合治疗慢性心力衰竭23例临床研究[J].江苏中医药，2017，49（1）：27-28.
[5] 蔡琳.《2007 ESC心力衰竭和超声协会对诊断左室射血分数正常心力衰竭的共识》如何诊断舒张性心力衰竭[J].心血管病学进展，2008，29（1）：17-20.
[6] 邓铁涛.实用中医诊断学（精）[M].北京：人民卫生出版社，2005：126.
[7] Jessup M，Abraham WT，Casey DE，et al. 2009 focused update：ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults：a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines：developed in collaboration with the International Society for Heart and Lung Transplantation [J]. Circulation，2009，53（15）：1977-2016.
[8] 全雨峰.益肾强心汤联合辅酶Q10对重症心力衰竭患者心功能、呼吸功能及运功能力的影响[J].现代中西医结合杂志，2017，26（8）：864-866.
[9] 郑筱萸.中药新药临床研究指导原则[M].北京：中国医药科技出版社，2002：126-128.
[10] 张长东，肖书娜，尚小珂，等.肺动脉高压患者压力-容积关系分析与纽约心脏病协会心功能分级的相关性[J].中国介入心脏病学杂志，2017，25（9）：512-519.
[11] Alkholy UM，Ahmed IA，Karam NA，et al. Assessment of left ventricular mass index could predict metabolic syndrome in obese children [J]. J Saudi Heart Assoc，2016， 28（3）：159-166.
[12] 国家中医药管理局.ZY/T001.1～001.9-94中医病证诊断疗效标准[M].南京：南京大学出版社，1994.
[13] 张勤帅，毛敏，杜守颖，等.60例慢性心力衰竭患者综合治疗的中西药用药分析[J].临床药物治疗杂志，2017， 15（4）：25-29.
[14] 贺小芳，唐蓓蕾，王显，等.益气活血利水方治疗冠心病心力衰竭气虚血瘀水饮证患者疗效分析[J].现代中医临床，2020，27（3）：9-12.
[15] 李星星，吴旸，林泉，等.益气活血利水方辅助治疗慢性心力衰竭气虚血瘀水停证的随机对照试验[J].中医杂志，2019，60（20）：1741-1746.
[16] 石磊，叶巍，刘果果.中医药在慢性心力衰竭患者中的应用进展分析[J].中国医药科学，2020，10（14）：47-50.
[17] 景雅婷，王凤荣，刘月.温阳益心法联合西药治疗充血性心衰的临床疗效[J].河北医学，2019，25（8）：1351-1356.
[18] 王洪图，李云.黄帝内经太素（修订版）[M].北京：科学技术文献出版社，2005.
[19] 任廷革.黄帝内经灵枢经[M].北京：人民军医出版社，2006：119-120.
[20] 巢元方.诸病源候论[M].北京：中国医药科技出版社，2011：11.
[21] 孙佳，张广平，苏萍，等.人参附子及其有效成分配伍对心脏表氧化酶CYP2J3、羟化酶CYP4A3和CYP4F11mRNA表达的影响[J].中国新药杂志，2019，28（17）：2081-2088.
[22] 周迎春，张廉洁，张燕丽.山茱萸化学成分及药理作用研究新进展[J].中医药信息，2020，37（1）：114-120.
[23] 刘晓霞.益肾强心汤联合西医常规治疗慢性心力衰竭临床观察[J].河北中医，2018，40（5）：734-737.
[24] 张松，廖宪勇，李白雪.中医治疗慢性心力衰竭的证候分析[J].四川中医，2020，38（2）：208-211.
[25] 欧阳红玲，田尧宇，郝春雪.hs-CRP持续升高与进展性脑梗死的关系研究[J].中国现代医学杂志，2017，27（29）：118-122.
[26] 谈云，叶琳岚，赵珺瑶，等.五味子丙素缓解血管紧张素Ⅱ诱导的心脏炎性反应和心肌重构[J].安徽医药，2020，24（7）：1291-1295.
[27] 李彦明，何瑞利，钟晓鸣，等.ACS患者外周血中vWF-cp、CatK、CysC及P选择素的变化及与冠脉病变的关系[J].东南大学学报：医学版，2019，38（1）：38-42.